Articles, App Notes, Case Studies, & White Papers

  1. Ensure High Quantity And Quality Of Isolated Bacterial Ribonucleic Acid 4/29/2022

    In this scientific brief we evaluate the performance of the Pall Nucleic acid binding (NAB) Nanosep centrifugal device for nucleic acid isolation.

  2. Regulatory Considerations For Excipients Used In Lipid Nanoparticles 8/15/2024

    Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.

  3. Addressing Challenges In mRNA Drug Development And Manufacturing

    mRNA-based drug products serve as an ideal platform for use in infectious disease, protein replacement, and immuno-oncology applications due to the simplicity of manufacturing and robust immune response.

  4. Genomic Medicine Demands Manufacturing Innovation 5/28/2024

    The promise of novel therapeutic modalities can only be realized when effective science is paired with efficient manufacturing to provide cost-effective therapies to patients in need.

  5. Oesophageal Cancer: Global Clinical Trial Landscape (2024) 8/19/2024

    Oesophageal cancer is the 11th most common cancer and the 7th leading cause of cancer deaths, starting in the esophagus. Explore our report to discover the latest in treatments, clinical trials, and future innovations.

  6. Mechanisms Of LNP-Mediated mRNA Delivery

    Explore the details supporting LNP-mediated mRNA delivery, as well as the challenges facing mRNA based therapeutics in the future.

  7. Overview Of Obesity: Global Clinical Trials Landscape 5/20/2025

    This comprehensive overview of current and emerging obesity treatments provides insight into the growing global health crisis that is rising in prevalence across all demographics and income levels.

  8. What ASCO 2025 Means For The Future Of Oncology Trials 6/13/2025

    Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.

  9. High-Throughput Platform Propels Gene Editing Therapy Research 3/1/2024

    Explore the potential of polymeric nanoparticles (PNPs) as an alternative to viral vectors. PNPs offer design flexibility, enabling larger payloads, targeted release, and minimized side effects.

  10. Consolidating The Supply Chain For mRNA 2/12/2024

    Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.